1. Home
  2. AUPH vs WBTN Comparison

AUPH vs WBTN Comparison

Compare AUPH & WBTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • WBTN
  • Stock Information
  • Founded
  • AUPH 1993
  • WBTN 2005
  • Country
  • AUPH Canada
  • WBTN United States
  • Employees
  • AUPH N/A
  • WBTN N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • WBTN
  • Sector
  • AUPH Health Care
  • WBTN
  • Exchange
  • AUPH Nasdaq
  • WBTN NYSE
  • Market Cap
  • AUPH 1.1B
  • WBTN 1.1B
  • IPO Year
  • AUPH 1999
  • WBTN 2024
  • Fundamental
  • Price
  • AUPH $7.94
  • WBTN $9.38
  • Analyst Decision
  • AUPH Strong Buy
  • WBTN Buy
  • Analyst Count
  • AUPH 2
  • WBTN 6
  • Target Price
  • AUPH $11.50
  • WBTN $12.92
  • AVG Volume (30 Days)
  • AUPH 1.6M
  • WBTN 269.4K
  • Earning Date
  • AUPH 07-31-2025
  • WBTN 08-07-2025
  • Dividend Yield
  • AUPH N/A
  • WBTN N/A
  • EPS Growth
  • AUPH N/A
  • WBTN N/A
  • EPS
  • AUPH 0.27
  • WBTN N/A
  • Revenue
  • AUPH $247,295,000.00
  • WBTN $1,347,441,000.00
  • Revenue This Year
  • AUPH $12.15
  • WBTN $9.01
  • Revenue Next Year
  • AUPH $18.31
  • WBTN $14.69
  • P/E Ratio
  • AUPH $28.55
  • WBTN N/A
  • Revenue Growth
  • AUPH 29.20
  • WBTN 3.71
  • 52 Week Low
  • AUPH $5.20
  • WBTN $6.75
  • 52 Week High
  • AUPH $10.67
  • WBTN $24.19
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 46.31
  • WBTN N/A
  • Support Level
  • AUPH $7.36
  • WBTN N/A
  • Resistance Level
  • AUPH $8.86
  • WBTN N/A
  • Average True Range (ATR)
  • AUPH 0.35
  • WBTN 0.00
  • MACD
  • AUPH -0.05
  • WBTN 0.00
  • Stochastic Oscillator
  • AUPH 31.43
  • WBTN 0.00

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About WBTN WEBTOON ENTERTAINMENT INC

Webtoon Entertainment Inc is a storytelling platform where a vibrant community of creators and users discover, create and share new content. It has pioneered a cultural movement by revolutionizing the storytelling format and democratizing content creation and publication connecting 24 million creators with approximately 170 million monthly active users in over 150 countries around the world.

Share on Social Networks: